Main Page
  
1-855-822-70-54           

Main Page

Русский
English
 
 
The CureLab Oncology team has gained approval from the Russian Federation Ministry of Health for clinical trials of its anti-cancer vaccine Elenagen® and started Phase I. Patients with solid tumors are currently being recruited to participate in the clinical trials. For any inquiries, please contact: , or  1-855-822-70-54 . For more detailed information on the clinical trials program, please follow this link:
Clinical trials
 



The CureLab Oncology team has gained approval from the Russian Federation Ministry of Health for clinical trials of its anti-cancer vaccine Elenagen® and started Phase I. Patients with solid tumors are currently being recruited to participate in the clinical trials. For any inquiries, please contact:, or 1-855-822-70-54. For more detailed information on the clinical trials program, please follow this link:

Clinical trials

Corporate Mission

CureLab Oncology is a biotechnology company that is developing new anti-cancer biologics. CureLab Oncology is committed to creating a family of revolutionary therapies for oncology patients in order to help prolong their lives.

Our Lead Product

Our lead product is an anti-cancer DNA vaccine, Elenagen® , that acts on a broad spectrum of primary tumors and metastatic processes. Elenagen® has successfully passed a full range of legally required preclinical toxicology tests and demonstrated significant anti-cancer potency in pilot studies with spontaneous tumors in dogs.
  
 
Разработка SEO-Online
Работает на Amiro.CMS - Free